1. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. (19th August 2013) Authors: Botton, Thomas; Yeh, Iwei; Nelson, Tyrrell; Vemula, Swapna S.; Sparatta, Alyssa; Garrido, Maria C.; Allegra, Maryline; Rocchi, Stephane; Bahadoran, Philippe; McCalmont, Timothy H.; LeBoit, Philip E.; Burton, Elizabeth A.; Bollag, Gideon; Ballotti, Robert; Bastian, Boris C. Journal: Pigment cell & melanoma research Issue: Volume 26:Number 6(2013:Nov.) Page Start: 845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗